Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized High-dose Inhaled Corticosteroid as Add-on Therapy in Asthma Exacerbation at Emergency Department
TCTR20201214001Phase 4Completed
- Sponsor
- Thammasat University
- Start
- Mar 2022
- Countries
- 1
01
Overview
Phase 4, randomised trial in asthma (2 arms), sponsored by Thammasat University. Started Mar 2022; status: completed.
02
Conditions
asthma
Beyond the preview
Go deeper on TCTR20201214001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201214001.